These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 38092472)
1. Cytogenetics and molecular genetics of myelodysplastic neoplasms. Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472 [TBL] [Abstract][Full Text] [Related]
2. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433 [TBL] [Abstract][Full Text] [Related]
3. TP53 in AML and MDS: The new (old) kid on the block. Marks JA; Wang X; Fenu EM; Bagg A; Lai C Blood Rev; 2023 Jul; 60():101055. PubMed ID: 36841672 [TBL] [Abstract][Full Text] [Related]
5. Risk stratifying MDS in the time of precision medicine. Cazzola M Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):375-381. PubMed ID: 36485160 [TBL] [Abstract][Full Text] [Related]
6. Familial myelodysplastic syndrome/acute myeloid leukemia. Churpek JE Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196 [TBL] [Abstract][Full Text] [Related]
7. The International Consensus Classification of myelodysplastic syndromes and related entities. Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH). Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642 [TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation. Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and classification of myelodysplastic syndromes. Hasserjian RP; Germing U; Malcovati L Blood; 2023 Dec; 142(26):2247-2257. PubMed ID: 37774372 [TBL] [Abstract][Full Text] [Related]
11. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Nardi V; Hasserjian RP Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274 [TBL] [Abstract][Full Text] [Related]
12. The current approach to the diagnosis of myelodysplastic syndromes Weinberg OK; Hasserjian RP Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039 [TBL] [Abstract][Full Text] [Related]
13. [Current state of treatment for myelodysplastic syndromes]. Ichikawa M Rinsho Ketsueki; 2023; 64(9):988-997. PubMed ID: 37793875 [TBL] [Abstract][Full Text] [Related]
14. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes. Banaszak LG; Reinig E; Lasarev MR; Mattison RJ Leuk Lymphoma; 2022 Mar; 63(3):684-693. PubMed ID: 34865601 [TBL] [Abstract][Full Text] [Related]
15. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation. Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N; Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702 [TBL] [Abstract][Full Text] [Related]
16. Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification. Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Ni SC; Yao M; Tseng MH; Kuo YY; Liu MC; Tang JL; Sun HI; Chuang YK; Chou WC; Hou HA; Tien HF Am J Hematol; 2023 Mar; 98(3):398-407. PubMed ID: 36588411 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults. Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075 [TBL] [Abstract][Full Text] [Related]
18. Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. Zavras PD; Sinanidis I; Tsakiroglou P; Karantanos T Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902450 [TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment. Marques FK; Sabino AP Biomed Pharmacother; 2022 Dec; 156():113905. PubMed ID: 36306593 [TBL] [Abstract][Full Text] [Related]